CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY Trademark

Trademark Overview


On Friday, August 20, 2021, a trademark application was filed for CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY trademark a serial number of 90894582. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, May 14, 2024. This trademark is owned by Seqirus Inc.. The CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

vaccines; vaccines for human use; flu vaccines

Medical information; pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics

Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development

General Information


Serial Number90894582
Word MarkCELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY
Filing DateFriday, August 20, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, May 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements


Goods and Servicesvaccines; vaccines for human use; flu vaccines
Goods and ServicesMedical information; pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics
NOT AVAILABLE"CELL-BASED ADJUVANT TECHNOLOGY"
Goods and ServicesProviding clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 7, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 7, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSeqirus Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHolly Springs, NC 27540

Party NameSeqirus Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHolly Springs, NC 27540

Trademark Events


Event DateEvent Description
Tuesday, August 24, 2021NEW APPLICATION ENTERED
Thursday, October 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 23, 2022ASSIGNED TO EXAMINER
Friday, May 27, 2022NON-FINAL ACTION WRITTEN
Friday, May 27, 2022NON-FINAL ACTION E-MAILED
Friday, May 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 20, 2023NON-FINAL ACTION E-MAILED
Wednesday, November 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 20, 2023NON-FINAL ACTION WRITTEN
Friday, January 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 15, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 14, 2024SOU EXTENSION 2 GRANTED
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 15, 2023SOU EXTENSION 1 FILED
Wednesday, November 15, 2023SOU EXTENSION 1 GRANTED
Friday, November 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 14, 2024SOU EXTENSION 2 FILED
Monday, November 18, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED